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Background: This paper describes the background, aim, and design of a prospective birth-cohort study in Korea
called the COhort for Childhood Origin of Asthma and allergic diseases (COCOA). COCOA objectives are to investigate
the individual and interactive effects of genetics, perinatal environment, maternal lifestyle, and psychosocial stress of
mother and child on pediatric susceptibility to allergic diseases.
Methods/Design: The participants in COCOA represents a Korean inner-city population. Recruitment started on
19 November, 2007 and will continue until 31 December, 2015. Recruitment is performed at five medical centers
and eight public-health centers for antenatal care located in Seoul. Participating mother-baby pairs are followed from
before birth to adolescents. COCOA investigates whether the following five environmental variables contribute causally
to the development and natural course of allergic diseases: (1) perinatal indoor factors (i.e. house-dust mite, bacterial
endotoxin, tobacco smoking, and particulate matters 2.5 and 10), (2) perinatal outdoor pollutants, (3) maternal prenatal
psychosocial stress and the child’s neurodevelopment, (4) perinatal nutrition, and (5) perinatal microbiome. Cord blood
and blood samples from the child are used to assess whether the child’s genes and epigenetic changes influence
allergic-disease susceptibility. Thus, COCOA aims to investigate the contributions of genetics, epigenetics, and various
environmental factors in early life to allergic-disease susceptibility in later life. How these variables interact to shape
allergic-disease susceptibility is also a key aim.
The COCOA data collection schedule includes 11 routine standardized follow-up assessments of all children at 6 months
and every year until 10 years of age, regardless of allergic-disease development. The mothers will complete multiple
questionnaires to assess the baseline characteristics, the child’s exposure to environmental factors, maternal pre- and
post-natal psychological stress, and the child’s neurodevelopment, nutritional status, and development of allergic and
respiratory illnesses. The child’s microbiome, genes, epigenetics, plasma cytokine levels, and neuropsychological status, the
microbiome of the residence, and the levels of indoor and outdoor pollutants are measured by standard procedures.
Discussion: The COCOA study will improve our understanding of how individual genetic or environmental risk factors
influence susceptibility to allergic disease and how these variables interact to shape the phenotype of allergic diseases.
Keywords: Cohort study, Gene-environment interaction, Allergy, Microbiota, Nutritional Status, Psychologic stress* Correspondence: jooshil@korea.kr; sjhong@amc.seoul.kr
†Equal contributors
16Allergy TF, Department of Immunology and Pathology, Korea National
Institute of Health, Osong Health Technology Administration Complex, 187
Osongsaengmyeong 2-ro, Yeonjae-ri, Osong-eup, Cheongwon 363-951,
Korea
7Department of Pediatrics, Childhood Asthma Atopy Center, Research Center
for Standardization of Allergic Diseases, University of Ulsan College of
Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, 760 Korea
Full list of author information is available at the end of the article
© 2014 Yang et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Yang et al. BMC Pulmonary Medicine 2014, 14:109 Page 2 of 12
http://www.biomedcentral.com/1471-2466/14/109Background
Allergic diseases such as asthma, atopic dermatitis, food
allergy, and allergic rhinitis are some of the most common
chronic diseases in the world [1]. In the past few decades,
the global prevalence of these diseases rose abruptly and
there is few signs that this trend is reversing itself. Indeed,
in many parts of the world [1-3], particularly in Asia (in-
cluding Korea) [4-7], the prevalence of allergic disease is
continuing to rise. During the same period, Korea has expe-
rienced rapid economic growth marked by industrialization,
modernization, urbanization, technological achievement,
high education levels, and greatly improved living stan-
dards. This phenomenon is termed colloquially as the
“Miracle on the Han River” [8] and has resulted in rapid
changes in the residential environment and the popula-
tion’s culture and dietary habits.
In human development, pregnancy is the most critical
period in terms of function and structure. The develop-
mental origins of health and disease (DOHaD) hypothesis
[9] postulates that all organ systems undergo developmen-
tal programming in utero that shapes the physiology and
metabolism of the adult. Indeed, there are multiple lines
of evidence that suggest that exposure to various environ-
mental variables in utero and during early childhood may
play a major role in susceptibility to allergic diseases.
Extensive epidemiological and laboratory studies have
been performed to identify the environmental causes of
allergic disease. Possible causes that have been studied
include maternal factors before or during pregnancy such
as disease, infection, diet, medication, and stress [10,11].
Various features of the indoor and outdoor environments
in the prenatal and postnatal periods have also been
examined. However, despite all this work, the etiology
of allergic diseases remains unclear [12]. This may be
due to the possibility that exposure to several envir-
onmental factors must occur before allergic disease is
triggered. It may also be due to human genetic differ-
ences that shape the susceptibility of different populations
or ethnicities to these triggers. Thus, susceptibility to aller-
gic disease is likely to be influenced by the individual’s
genetic background, maternal factors during pregnancy,
and environmental factors in the perinatal period, and
complex interactions between these factors. Since various
factors, including race, culture, socioeconomic status,
and place of residence, determine the degree of ex-
posure to various environmental triggers, birth cohort
studies are vital for identifying these gene-environment
and environment-environment interactions [13]. Since
Korea has a highly genetically homogeneous population
that has undergone marked environmental changes re-
cently, birth-cohort studies in this country are likely to
yield interesting data that will illuminate the influence of
rapid environmental deterioration on the development
of allergic disease.The COhort for Childhood Origin of Asthma and al-
lergic diseases (COCOA) birth-cohort study is currently
underway. It is designed to investigate the causal contri-
bution of the following five environmental factors to the
development and natural course of allergic diseases:
(1) perinatal exposure to indoor factors (namely, house-
dust mites, bacterial endotoxins, tobacco smoking, and
particulate matter 2.5 and 10), (2) perinatal exposure to
outdoor pollutants, (3) perinatal maternal psychosocial
stress, (4) perinatal nutrition, and (5) the perinatal micro-
biome. Thus, the COCOA study will help to delineate
how these environmental factors interact with each other
and the genetic background of the child during this crit-
ical time point in the child’s life (Figure 1). The study will
consist of two investigation stages. The first will assess
whether the perinatal factors act as individual risk factors
for (a) the development of atopy, atopic dermatitis, food
allergy, and recurrent wheeze in infancy, (b) the persist-
ence of these diseases at the age of 10 years, and (c) the
development of asthma and allergic rhinoconjunctivitis by
the age of 10 years. The second stage will assess whether
the ability of each perinatal variable to act as a risk factor
for allergic disease is shaped by the other perinatal factors
and/or the child’s genetics.
Genetics
Genetic predisposition seems to be the biggest risk fac-
tor for allergic diseases. However, genes alone cannot ex-
plain the rising global prevalence of these diseases over
the world because human evolution occurs over many
centuries rather than over decades. Instead, it is likely
that interaction between genes and the environment
shape the phenotype of allergic disease. Supporting the
role of the environment is that allergic diseases are more
prevalent in developed countries than in developing
countries. Moreover, the urban areas in Asian countries
have higher prevalence rates of allergic diseases than
rural areas [4,14]. Supporting the role of the genes is
that Asian metropolises such as Seoul, Singapore, and
Hong Kong in Asia still have relatively lower allergic dis-
ease prevalence and disease severity than metropolises
in the United Kingdom and Australia [3]. The fact that a
rapid change to Westernized culture and environments
correlates positively with increased allergic disease preva-
lence but that differences remain between ethnic popula-
tions despite their similar environments suggests strongly
that allergic disease susceptibility is shaped by interactions
between genes and the environment. It is possible that
when these interactions occur in the prenatal and/or post-
natal periods, they induce epigenetic changes that later
systematically influence the expression or suppression of
genetic responses to environmental stimuli, thereby
promoting or suppressing the development of allergic
diseases [15].
Figure 1 The COCOA study is designed to investigate the causal contribution of the following five environmental interventions to the
development and natural course of allergic diseases: (1) perinatal exposure to indoor factors (namely, house-dust mites, bacterial
endotoxins, tobacco smoking, and particulate matter 2.5 and 10), (2) perinatal exposure to outdoor pollutants, (3) perinatal maternal
psychosocial stress, (4) perinatal nutrition, and (5) the perinatal microbiome.
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ous ages and their exposures to various environmental
factors at those ages will be measured. In this way, the
epigenetic changes of the children at these ages can be
assessed for correlations with specific environmental fac-
tors. Since epigenetic changes can pass into the next
generation, such epigenetics research may help to iden-
tify the most effective long-term methods of preventing
allergic diseases.
The environment
The role of the environment in allergic disease has be-
come the subject of increasing attention in the field of
allergic disease management because its key role in the
development of allergic disease suggests that it could
be manipulated by preventive or therapeutic strat-
egies. Air pollution resulting from industrialization, rapid
urbanization, and the rising use of automobiles is of par-
ticular interest because the recent increases in allergic
disease prevalence are largely attributed to these en-
vironmental changes. It is believed that air pollution may
alter immune-programming via epigenetic mechanisms,
especially in the prenatal and perinatal periods. Both out-
door and indoor air pollution are of interest. However, in-
door pollution may have a greater influence on allergic-
disease susceptibility because infants and young children
spend most of their time indoors. In addition, indoor air
pollutant concentrations can be 2 to 5 fold higher than
outdoor levels. For this reason, the indoor and outdoorpollution exposure of the children will be measured at
various ages in the COCOA study.
Nutrition
Diet is arguably one of the most important environmental
exposures in early life. The immune system is a extremely
dynamic and metabolically active network that depends on
dietary nutrients and its functions are highly sensitive to
dietary changes [16]. Thus, dietary change is a logical candi-
date as a culprit responsible for the rise in allergic diseases.
Supporting this is that the modern increase of caloric intake
and dietary fat in the “Western diet” correlates with rises in
prevalence of both metabolic and immune-mediated dis-
eases [17]. By contrast, the Mediterranean diet associates
with protection from childhood asthma and wheeze [18].
The protective elements within these diets are likely to
include selenium, zinc, folate, vitamin E, and other antioxi-
dants. However, specific supplementation with these mole-
cules has had inconsistent and even paradoxical effects
[19]. These inconsistencies may relate to complex interac-
tions between specific nutrients and additional interactions
with other modern environmental changes such as the hu-
man microbiome, stress, and air pollution. To identify these
interactions, the COCOA study examines the maternal diet
during pregnancy and the child’s diet at various ages.
The microbiome
The “microflora hypothesis” proposes that, rather than
specifically limiting infection, the hygienic western lifestyle
Yang et al. BMC Pulmonary Medicine 2014, 14:109 Page 4 of 12
http://www.biomedcentral.com/1471-2466/14/109limits general microbial exposure and thereby alters the
colonization of the human gut, which in turn disrupts the
appropriate development of immune systems and ultim-
ately promotes the development of allergic diseases
[14,15,20-23]. Infancy and early childhood have been iden-
tified as important periods for the development of gut
microbiota and allergic diseases, respectively [24]. The
emerging understanding of the importance of microbial
contact during the vulnerable periods of fetal life, delivery,
and infancy for healthy immune and metabolic program-
ming creates new opportunities to improve infant health
and reduce the risk of disease in later life. However, the
underlying mechanism, the cause-effect relationship, and
particularly the identification of helpful individual mi-
crobes and microbial compounds remain to be established
and discovered. The hypothesis in the COCOA study is
that microbial composition in early life is an important
risk factor for allergic diseases in later life. To prove this,
we will sample the fecal and skin microbiomes of the chil-
dren at various ages and will seek to identify the factors
that alter the microbial composition and function. The ef-
fect of changes in the microbiome on the metabolomics of
the child will also be assessed.
Maternal psychosocial stress and the child’s
neurodevelopment
Psychological distress and allergic diseases show high co-
morbidity [25]. Moreover, there is evidence that psycho-
logical distress and allergic diseases have a bidirectional
relationship [26,27]. A recent study showed that prenatal
maternal distress promoted the development of allergic
disease in the offspring [28]. However, the underlying
mechanisms and a cause and effect relationship have not
been elucidated, although there is some evidence that the
underlying mechanisms may involve the hypothalamic-
pituitary-adrenal axis [29].
In the COCOA study, to assess the interactive rela-
tionship between psychological distress and allergic dis-
eases, the mother will be assessed for prepartum and
postpartum depression and anxiety. The relationship be-
tween this stress and the development of allergic disease
in the offspring will then be assessed. Furthermore, the
child’s development and temperament and the presence
of behavioral and psychological problems will be mea-
sured at various ages to determine whether it is influ-
enced by maternal psychosocial stress and promotes
the development of allergic disease. Whether the child’s
neurodevelopment independently affects allergic disease
susceptibility will also be tested. Thus, the COCOA birth-
cohort study will comprehensively analyze the interactions
between numerous factors within a genetically homoge-
neous ethnic population. COCOA will then be compared
to other birth cohort studies in different ethnic popula-
tions with similar environments to further improve ourunderstanding of the gene-environmental interactions in
early life that promote or suppress the development of al-
lergic diseases in later life. Ultimately, we expect that these
investigations will provide better global strategies for the
prevention and treatment of allergic diseases.
Methods/Design
Study population and setting
Seoul is the capital of South Korea and its largest me-
tropolis: more than 10 million people (more than one-
fifth of the total Korean population lives in Seoul) live in
605.41 square kilometers. Seoul has one of the highest
population densities in the world (24,214/km2 in 2013
[30]): indeed, it is most densely populated metropolis of
all the cities belonging to the Organization for Economic
Co-operation and Development (OECD). Seoul also con-
sists largely of a single ethnic population: 97.5% of its in-
habitants have Korean ethnicity [31]. In addition, it is a
highly developed city, ranking twelfth in the world in
terms of gross domestic product (GDP). With a GDP of
US$773.9 billion in 2012, it is also the fourth largest
metropolitan economy after Tokyo, New York, and Los
Angeles [32]. Finally, it is an extensively industrialized
city that in 2013 had 2.8 million cars [33]. Thus, the
Seoul population is an appropriate representative of
Korean inner-city populations.
The COCOA network consists of five medical centers
(the Asan, CHA Gangnam, Samsung, Seoul National, and
Severance Medical Centers) and eight Public Health Centers
for antenatal care (Gandong-gu, Gangnam-gu, Gwangjin-
gu, Mapo-gu, Seocho-gu, Seodaemun-gu, Songpa-gu, and
Yeongdeungpo-gu). All are located in Seoul, Korea. Their
geographical locations are provided by Figure 2. The main
center is Asan Medical Center, which contains the gen-
etics, epidemiology, environmental data constructing,
in vivo and in vitro studies, nutrition, and psychology
research teams.
Study design
The COCOA study is a collaborative multi-center pro-
spective birth-cohort study that is sampling nine regions
of Seoul city to recruit a mother-child pair cohort that is
representative of a Korean inner-city population. Its aims
are to investigate whether genetics, maternal life-style,
maternal and child’s psychological stress, and perinatal
exposure to various environmental factors influence the
development by the offspring of atopy and respiratory
tract infections (RTI) early in life and allergic diseases in
young adulthood. Whether and how these various factors
interact with each other to shape susceptibility to allergic
diseases will also be assessed. Recruitment of participant
women and baby pairs started on 19 November, 2007 and
will end on 31 December, 2015. The plan is to follow all
trios of participant women, husband, and babe from
Figure 2 The COCOA network consists of five medical centers (the Asan, CHA Gangnam, Samsung, Seoul National, and Severance
Medical Centers) and eight Public Health Centers for antenatal care (Gandong-gu, Gangnam-gu, Gwangjin-gu, Mapo-gu, Seocho-gu,
Seodaemun-gu, Songpa-gu, and Yeongdeungpo-gu). All are located in Seoul, Korea.
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the study may be extended to follow up the offspring until
they are 20 years of age.
Before commencement of the study, the study was ap-
proved by the Institutional Review Boards of Asan Med-
ical Center (IRB No. 2008–0616), Samsung Medical
Center (IRB No. 2009-02-021), Severance Medical Cen-
ter (IRB No. 4-2008-0588), and CHA Gangnam Medical
Center (IRB No. 2010–010).Seoul National University
Hospital (IRB No. H-1401-086-550) joined the COCOA
later and started recruiting in February, 2014. Written
informed consent was obtained from each mother and
their husband before the study-related interview was
performed. The obtainment of consent was confirmed
by each IRB.
Study subjects (inclusion and exclusion criteria)
All eligible consecutive pregnant women who attend
any of the five medical centers in Seoul (i.e. the Asan,
Samsung, Severance, and CHA Gangnam Medical Centers,
and Seoul National University Hospital) before 26 weeks
of gestational age are asked whether they would like to
participate in the COCOA study. The eligibility of thewomen is identified before recruitment. A woman is re-
cruited if she lacks high-risk conditions that could affect
the development of allergic disease in the child (e.g. dia-
betes, preeclampsia, anemia, and severe infections), plans
to deliver at an affiliated medical center, and is a resident
of Seoul city. The eligibility of the baby is determined by
the collaborating obstetrician and pediatrician soon after
delivery. Babies are excluded at birth if their gestational
age is < 37 weeks or they have any major congenital anom-
alies or birth asphyxia requiring oxygen supplementation.
The main purpose of the COCOA study was introduced
with emphasis on their child’s general health to reduce the
possibility to become high-risk cohort.
Overview of the study process
This study is a longitudinal prospective birth-cohort study
that will assess all offspring at birth and at 11 routine
follow-up visits at 6 months and 1, 2, 3, 4, 5, 6, 7, 8, 9, and
10 years of age, regardless of whether the offspring develop
allergic diseases. Clinical evaluations, including objective
measurements of allergic diseases such as atopic derma-
titis, food allergy, bronchiolitis, RTI, recurrent wheezing,
asthma, and allergic rhino-conjunctivitis, are performed at
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ized protocol (described in detail below). The delivery rec-
ord of each infant is collected at birth in each center. Cord
blood samples are collected from subjects at the time of
delivery. Serial questionnaires are completed by the mother
at enrollment and every scheduled visit to assess the base-
line characteristics, nutritional status, psychological stress/
development, development of allergic and respiratory ill-
ness, and exposure to various environmental factors. The
study schedule is detailed in Table 1.
Data collection
Questionnaires
The mothers complete a modified version of the International
Study of Asthma and Allergies in Childhood (ISAAC)
questionnaire [34] at 36 weeks gestation. A series of ques-
tionnaires on confounding variables, maternal and child’s
lifestyle (i.e. nutrition and psychological stress), and peri-
natal exposure to various indoor and outdoor environ-
mental factors are obtained at 36 weeks gestation and
every scheduled visit thereafter.
All mothers are asked to complete a questionnaire
about their residential environment before and after the
birth of their child. The following environmental factors
are assessed: 1) residence characteristics (e.g. the type of
building and floors, whether and when indoor renova-
tion has been performed, whether and when the family
have moved into a newly constructed house , etc.), 2) what
type of stove is used for cooking and how the house is
heated, 3) whether there are indoor domestic pets,
4) which organic chemical compounds (insecticide and
detergent use) are used and when, and 5) whether the in-
door air quality is affected by the presence of traffic roads
near the home. Other factors that affect indoor air quality
(e.g. parental smoking patterns) are also assessed. After
birth, an additional questionnaire is given on a regular
basis to determine the details of daycare center attend-
ance, antibiotic use, and the development of respiratory
symptoms of the offspring. This questionnaire has been
validated previously and also includes questions about
whether the child has eaten 113 food items during the
preceding year. The amount of each food item that was
eaten is measured by using nine non-overlapping intake
frequencies (ranging from “rarely eaten” to “eaten more
than three times per day”) together with three portion
sizes (small, average, and large) [35]. The food and dietary
intake is assessed by using a computerized nutrient-intake
assessment software program (CAN-Pro 3.0; Korean
Nutrition Society, Seoul, Korea) [36].
Maternal psychological distress is measured at 26, and
36 weeks of pregnancy, and at the time of birth. At the
third trimester of pregnancy, the Center for Epidemio-
logical Studies-Depression (CESD), State-trait Anxiety
Inventory (STAI), Perceived Stress Scale (PSS), andMaternal Fetal Attachment Scale (MFAS) are used to
measure maternal depression, anxiety, perceived stress,
and maternal fetal attachment, respectively. After deliv-
ery, the Satisfaction with Life Scale, Korean Marital Sat-
isfaction Inventory and Korean Parent Stress Index, as
well as CESD and STAI, are used yearly to assess the ma-
ternal psychological state. The neurodevelopment of the
child is evaluated by a series of questionnaires. The Korean
Age and Stages Questionnaire, the Infant-Toddler Social
and Emotional Assessment, and the Modified Checklist for
Autism in Toddlers are completed at the scheduled visits.
The infant’s temperament is assessed by using the Infant
Behavior Questionnaire-Revised-Short Form, while the re-
lationship between the parents and the child is measured
by Parenting Relationship Questionnaire.
Blood samples for measuring gene expression and cytokine
levels and to obtain DNA
The collaborating obstetricians are directly involved in
the delivery and collect the cord blood at birth according
to a standard protocol. Paternal blood is obtained at
birth while maternal blood is obtained when the child is
6 months of age. Blood is also obtained from the child at
the first, third, sixth, and ninth birthdays.
The cord blood is collected into a blood bag contain-
ing CPDA1 anticoagulant, after which the COCOA co-
ordinator transports the bag to the laboratory in the main
center. It is maintained at room temperature pending pro-
cessing for less than 24 hours after collection until pro-
cessing. The mononuclear cells in the cord blood are
isolated by using the density gradient separation method
and then cultured according to the method described by
our previous study [37]. The culture supernatant is tested
for the cytokine responses.
Plasma is generated from parental and child blood sam-
ples and analyzed at a central laboratory for the presence
of antibodies to allergens. DNA from the cord blood sam-
ple and the peripheral blood samples of the parents and
child are stored for subsequent genetic studies.
Urine analysis
Urine samples are collected at 36 weeks of pregnancy or
before delivery from the mother and at the ages of 3, 6
and 9 years from the child. Midstream specimens are
collected and subjected to routine urinalyses. At the ages
of 3, 6, and 9 years, the concentrations of phthalate me-
tabolites and cotinine in the urine are also measured.
Phthalate metabolites are measured as described by the
Center for Disease Control and Prevention Laboratory
Procedure Manual [38].
Physician’s examination of the child
Health examinations of the child are performed at birth and
each scheduled visit by pediatric allergy and pulmonology
Table 1 Data collection schedule of the COhort for Childhood Origin of Asthma and allergic diseases (COCOA) study
Scheduled visits of the mother-child pair
when the child is the indicated age
Enrollment
(26th GA)
36th
GA Birth 1 mo 6 mo 1 yr 2 yrs 3 yrs 4 yrs 5 yrs 6 yrs 7 yrs 8 yrs 9 yrs 10 yrs
Informed consent √ √
General questionnaire
Maternal eligibility √ √
Familial demographics √ √
Familial socioeconomic status √ √
Familial history of allergic and
respiratory diseases
√ √
Maternal health questionnaires
Maternal general health √ √ √
Maternal life style √ √ √
Maternal diet/nutrition √ √ √
Maternal psychosocial stress √ √ √ √ √ √ √
Child’s health questionnaire √ √ √ √ √ √ √ √ √ √ √
Child’s general health √ √ √ √ √ √ √ √ √ √ √
Child’s diet/nutrition √ √ √ √ √ √ √
Child’s medication √ √ √ √ √ √ √ √ √ √ √
Child’s allergic and respiratory illness √ √ √ √ √ √ √ √ √ √ √
Child’s psychological development √ √ √ √ √ √ √ √ √
Physician’s examination of child √ √ √ √ √ √ √ √ √ √ √ √
Clinical measurement
SCORAD index √ √ √ √ √ √ √ √ √ √ √
Allergy skin test
Mother √
Father √
Child √ √ √
Spirometryof child √
IOS of child √
FeNO of child √
Methacholine challenge test √ √
Respiratory virus
(nasopharyngeal aspiration)
At every episode of
respiratory viral illness
Blood sampling
Maternal blood √
Paternal blood √
Cord blood √
Child’s blood √ √ √ √ √*
Urine sampling of child √ √ √
Feces sampling of child √ √ √ √
Skin microbiome of child √ √ √
X-ray (bone-age) of child √
Questionnaire about the
indoor environment
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Table 1 Data collection schedule of the COhort for Childhood Origin of Asthma and allergic diseases (COCOA) study
(Continued)
Indoor environment assessment √ √ √ √ √ √ √ √ √ √ √ √
Dust sample collection √ √
Indoor air-pollutant measurements √
Microbial sample collection √ √
Outdoor air-pollutant assessment √ √
*LH, FSH measurement at 9 years of age.
Abbreviations: FeNO Fractional exhaled nitric oxide, FSH Follicle-Stimulating hormone, GA Gestational age, IOS Impulse oscillometry, LH Luteinizing hormone,
SCORAD Scoring atopic dermatitis.
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ing to a standardized procedure for any abnormal signs
such as throat infection, postnasal drip, erythema or bul-
ging of the tympanic membrane, and wheezing. At the
same visit, the body weight and height of the child are
measured to the nearest 0.1 kg and 0.1 cm while the child
wears light indoor clothing and without shoes. A certified
nurses uses an automatic BP recorder to measure the
child’s blood pressure (BP) a maximum of three times on
the right arm while the child is seated and after the child
has rested for 5 min.
Examination of the neuropsychological development of the
child
At each follow-up visit, the psychological development
of the child is evaluated. The free play, Mullen Scales of
Early Learning, and Still Face procedures are conducted
at 6 months of age. The strange situation procedures as
well as free play and Mullen scales are conducted at
12 months of age. The Preferential Looking Paradigm,
the Korean Wechsler Preschool and Primary Scale of
Intelligence, and Korean Wechsler Intelligence Scale for
Children-IV are employed at 2, 4, and 6 years of age.
Assessment of exposure to indoor and outdoor
environmental factors
Outdoor air pollution The concentrations of ambient
air pollutants in various areas of Seoul at various times
are compiled by using air monitoring data that are re-
corded routinely by monitoring stations operated by the
Department of Environment, Republic of Korea. Each
monitoring station measures the gaseous pollutants
[nitrogen dioxide (NO2), ozone (O3), carbon monoxide
(CO), and sulfur dioxide (SO2) and particulate matter
(PM) hourly. These data are used to determine the daily,
monthly, and yearly averages of these pollutants in the
area around the monitoring station. These data in turn are
used to estimate the exposure of the people living in the
monitored area at the time of interest: for this, the kriging
method using GIS (Geometric Information System) (Arc-
Map, version 9.3; ESRI Inc., Redlands, WA, USA) is used
[39]. However, land-use regression models will eventuallyreplace the kriging method for estimating the level of ex-
posure. Previous exposure values will be replaced by using
this method.
Indoor air pollution At 36 weeks of pregnancy, the in-
door air pollutant concentrations in the mother’s resi-
dence are measured. The following will be measured:
PM10 and PM2.5, biological aerosols (airborne bacteria
and fungi), indoor aeroallergens (house-dust mite), and
endotoxin. Mini-volume Air Sampler, Model 4.1 (Air
metrics Co, USA) is used to sample particulate matters.
Each sample collection is conducted in the mother’s room
for 24 h at a constant sampling flow rate of 10 L/min.
Samplers are positioned at least 1 meter away from the
walls, ceiling, and door, and 1.2-1.5 meters above the floor.
The particulate matters are measured by using a particle
discriminator (Model GT-331, SIBATA Co., Japan) with a
laser light-scattering optical particle counter. Microbial
sampling is performed by using a Single Stage Air Sampler
at the same place the particulate matters are sampled.
Bacterial aerosols and airborne fungi are cultivated in
Tryptic Soy Agar and Sabouraud Dextrose Agar for 24 hr
at 24°C and room temperature, respectively. The colony-
forming units (CFU) per m3 are calculated by dividing
the CFU value by the indoor air volume. Dust sam-
ples are collected from a 1×1 m2 bedding surface for
2 min by using a vacuum cleaner in which the dust filter is
fixed to allow even dust collection. After being put into
Ziplock Bags to prevent the dust from being brushed
off, the collected dust is kept cold (below −4°C) until
analysis. Thereafter, 100 g and 50 g of each dust sam-
ple are used to measure house-dust mite and endo-
toxin, respectively as described elsewhere [40]. Briefly,
Der f 1 (Dermatophagoides farinae) and Der p 1 (Derma-
tophagoides pteronyssinus) are measured by calorimetric
analysis using an ELISA (Enzyme-Linked Immunosorbent
Assay) Reader (Molecular Device, VersaMax). Endo-
toxin is determined by kinetic chromogenic analysis
where a spectrophotometer is employed at a wave
length of 405 nm according to the standard method
described by the American Society for Testing and
Materials [40].
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Fecal and skin samples are obtained from the children at
the age of 1 month, 6 months, 3 years, and 6 years of
age. The microbiome sampling and DNA extraction
methods have been described in detail elsewhere [23,41].
The microbiome of the indoor environment is also ob-
tained at 36 weeks of pregnancy by the wiper method
and from dust samples taken at the same time [42].
Outcome assessments
Skin prick tests Skin prick tests (SPTs) are performed
in the child on the third, sixth and ninth birthdays, in
the father at the time of the child’s birth, and in the
mother when the child is 6 months of age. ALK allergen
solutions serve as allergen extracts and 10 mg/mL of hista-
mine dihydrochloride and saline serve as positive and
negative controls, respectively (Allergopharma, Reinbek,
Germany) [43]. The longest length and width (measured
perpendicular to the length at its midpoint) of the wheal
are measured to the nearest millimeter after 15 min and
are expressed as mean wheal size [44]. A child is deemed
to have atopy when at least one common allergen evokes a
positive response (wheal diameter ≥ 3 mm) and the mean
wheal diameter to histamine exceeds 3 mm [45]. A child is
deemed to be non-atopic when all common allergens yield
a negative SPT response. The SPTs are performed with
18 common allergens for children (i.e. Der f 1, Der p 1,
German cockroach, grasses mixture, alder, birch, oak,
Japanese hop, mugwort, ragweed, dog epithelium, cat
epithelium, Alternaria alternata, Aspergilus fumigatus,
peanut, cow’s milk, egg white, and soybean), and 14 com-
mon allergens for parents (i.e. Der f 1, Der p 1, German
cockroach, grasses mixture, Trees I, Trees II, mugwort,
ragweed, dog epithelium, cat epithelium, Alternaria alter-
nata, Aspergilus fumigatus, oak, and alder) [43].
Total serum IgE Total serum IgE concentration in the
child and their parents is measured by using a fluores-
cent enzyme immunoassay (AutoCAP System; Pharma-
cia Diagnostics AB, Uppsala, Sweden).
Respiratory infection and bronchiolitis RTIs are de-
fined as acute nasopharyngitis, rhinosinusitis, otitis
media, croup, tracheobronchitis, bronchiolitis, or pneu-
monia. A child is deemed to have had an RTI when the
mother responds positively to a series of questions about
typical symptoms during each follow-up period or the
family pediatrician who examined the child during the
follow-up period has diagnosed RTI. Acute nasopharyn-
gitis is diagnosed when there is an episode of runny/
blocked nose or cough in the absence of other respiratory
symptoms (i.e. no tachypnea, difficulty breathing, wheez-
ing or rattly chest). Rhinosinusitis is diagnosed when two
or more of the following symptoms that last at least10 days occur during the follow-up period: anterior and/
or posterior mucopurulent drainage, nasal congestion or
blockage, cough, facial pain, pressure, or dullness, or a re-
duced or absent sense of smell [46]. Otitis media is diag-
nosed when there are signs and symptoms of inflammation
in the middle ear [47]. Croup is diagnosed when there is an
episode of the characteristic “barking” cough, hoarseness,
and inspiratory stridor. Tracheobronchitis is diagnosed
when its signs and symptoms, including a frequent, dry,
hacking cough that lasts about 2–3 weeks, are preceded
by upper respiratory infection symptoms such as rhinitis.
Bronchiolitis is defined as wheezing [48] that is diagnosed
by a physician during the follow-up period or by pediatri-
cians and pediatric allergy and pulmonology specialists at
the scheduled visits. Wheeze status is also assessed by ask-
ing the following at each visit: “Has he/she had wheezing
or whistling in the chest at any time?” Pneumonia is diag-
nosed when its signs and symptoms are observed, in-
cluding crackle, tachypnea, increased work of breathing
accompanied by intercostal, subcostal, and suprasternal
retractions, nasal flaring, the use of accessory muscles,
cyanosis, and respiratory fatigue [49].
Food allergy Food allergy is assessed at every scheduled
visit by asking via a questionnaire whether a doctor had
ever diagnosed food allergy in the offspring, whether
food was suspicious, and whether medications had been
prescribed for the condition. If there was a positive re-
sponse, the diagnosis of food allergy was then confirmed
by a pediatric allergy specialist during follow-up at
each hospital. Moreover, the sera of the children taken at
12 months of age were tested for IgE antibodies specific
for cow’s milk and egg white by using the Phadia Immmu-
noCAP system (Phadia Diagnostics, Uppsala, Sweden). If
the doctor believed that another food allergen was causing
food allergy, antibodies against that food allergen were
measured. The eligibility of the child for an open food
challenge test was then determined on the basis of this
information.
Atopic dermatitis Atopic dermatitis is assessed at every
scheduled visit by asking via questionnaire whether a doc-
tor had ever diagnosed atopic dermatitis and whether me-
diations for the condition have been prescribed. When the
infants are followed-up at the hospital, the presence of
atopic dermatitis is clinically diagnosed by pediatric allergy
specialists on the basis of the criteria of Hanifin and Rajka
[50]. In children with atopic dermatitis, the physical exam-
ination conducted at the time of every-scheduled visits in-
cluding standard scoring for signs of eczema using the
Scoring Atopic Dermatitis (SCORAD) assessment [51].
Recurrent wheeze Episodes of wheezing are identified
by the questionnaire or the history taken by pediatric
Figure 3 Current status of the COCOA study. A total of 1871
pregnant women have consented to participate in COCOA. Of these,
294 have withdrawn their consent and 35 have been lost to follow
up. In addition, 82 women have been excluded, the most common
reason being preterm birth. The remaining 1460 women have
delivered 1364 infants, including 28 pairs of twins.
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have had three or more life-time episodes of wheezing, at
least one of which has been confirmed by doctors.
Allergic rhinitis Allergic rhinitis is suspected when the
subject complains of relevant rhinitis symptoms (i.e. watery
rhinorrhea, nasal obstruction, sneezing or itching). If a de-
tailed history taken by doctors reveals that the subject has
had allergic sensitization and presents with typical rhinitis
symptoms for a sufficient period of time (for two or more
consecutive days, and for more than 1 hour on most days),
the subject is diagnosed with allergic rhinitis [52].
Bronchial hyperresponsiveness (BHR) and lung-function
measurements Pulmonary functions are assessed via vari-
ous measures appropriate for the participant’s ability and
age. Impulse oscillometry (at the age of 4) and exhaled ni-
tric oxide analysis (at the age of 5) are conducted in a sub-
set of participants who volunteer to undergo the analysis.
All subjects undergo pulmonary function tests at the age
of 7 via conventional spirometry. BHR is assessed by
measuring the concentration of methacholine that causes
a 20% fall in FEV1 (PC20). When the PC20 is 16 mg/mL or
less, the subject is diagnosed with BHR regardless of the
clinical history assessed by the questionnaire.
Asthma Asthma is assessed by various outcome mea-
sures. Typical asthma symptoms (i.e. wheezing, dyspnea,
exercise-induced wheezing or nocturnal cough) are
assessed by questionnaires on the regular visits at the
ages of 6 months, 1 year, and then yearly thereafter when
pediatric allergists also evaluate each subject on the basis
of their detailed history and the physical exam. Asthma
is diagnosed when subjects present a history of relevant
asthma symptoms plus BHR or reversible airway ob-
struction. For preschool children who cannot conduct
reliable lung function tests, subjects who have had three
or more episodes of wheezing are deemed to have
asthma if the pediatric allergists confirm this.
Management of study quality The study data are man-
aged by the Data Coordinating Center (DCC) that is lo-
cated at Asan Medical Center. The questionnaires are
gathered and encoded on optical mark recognition (OMR)
cards by a trained clinical research center (CRC) nurse at
each research site. The cards are then transferred to the
DCC, where they are scanned and uploaded into the cen-
tral database after CRC nurses at the DCC check for input
errors. Follow-up calls are made by the data manager at
DCC to verify data that are missing or contradictory.
Personnel from the DCC visit each center yearly to review
all aspects of data acquisition and transfer. The CRC
nurses undergo bi-annual training sessions on the standard
operating procedures (SOPs) for interviewing participantsand coding data. As part of the quality control process, the
database is subjected to periodic audits.
Biological samples are transferred and liquoted to the
central laboratory immediately after the acquisition.
After being appropriately treated, the samples are trans-
ferred to and stored at the Department of Immunopa-
thology in the Korean National Institute of Health. The
time spent transferring samples is minimized by using a
specialized commercial service. The kinds and amounts of
transferred samples are recorded on a separate manage-
ment log at each site. For quality control and assurance,
SOPs for collecting, processing and storing samples are
established and followed.
Current status
At the time of writing (May, 2014), 1871 pregnant women
have consented to participate in COCOA. Of these, 294
have withdrawn their consent and 35 have been lost to fol-
low up. In addition, 82 women have been excluded, the
most common reason being preterm birth. The remaining
1460 women have delivered 1364 infants, including 28
pairs of twins (Figure 3).We expect to have 2500 pairs of
pregnant women and offspring at the end of enrollment
and that 250 children with asthma will be identified at
10 years of age.
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